Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hcv Harvoni'

Hcv Harvoni published presentations and documents on DocSlides.

Boceprevir

Boceprevir

  • aaron
  • 7 Slides

with PEG + RBV in Genotype 1. SPRINT. -1. Phase ....

Boceprevir in Treatment Naive

Boceprevir in Treatment Naive

  • min-jolicoeur
  • 7 Slides

SPRINT-2. Phase 3, Treatment . Naive. Treatment. ...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

  • giovanna-bartolotta
  • 9 Slides

VALENCE Trial. Phase . 3. Treatment. Naïve and ...

Estimates of People with Hepatitis C in Indiana

Estimates of People with Hepatitis C in Indiana

  • cheryl-pisano
  • 4 Slides

Number People with Reactive anti-HCV Antibody. Un...

OBV/PTV/r

OBV/PTV/r

  • conchita-marotz
  • 5 Slides

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

  • aaron
  • 4 Slides

qd. Non-randomised. Open-label. N =. 21. W12. SV...

Ehab Abd-El-Atty

Ehab Abd-El-Atty

  • myesha-ticknor
  • 39 Slides

Hepatitis-2015. Orlando, USA. July 20 - 22 2015...

CROI 2015: What’s New in Hepatitis?

CROI 2015: What’s New in Hepatitis?

  • myesha-ticknor
  • 19 Slides

Nina Kim, MD . Associate Professor of Medicine. D...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

  • debby-jeon
  • 10 Slides

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

Shruti H. Mehta, PhD MPH

Shruti H. Mehta, PhD MPH

  • danika-pritchard
  • 18 Slides

Associate Professor, Johns Hopkins Bloomberg Scho...

Peginterferon alfa-2a +

Peginterferon alfa-2a +

  • stefany-barnette
  • 8 Slides

RBV . versus. Interferon alfa. -. 2a + RBV . ACT...

Last

Last

  • yoshiko-marsland
  • 35 Slides

Updated: . July . 6. , . 2015. Treatment of Hepat...

ALLY-2

ALLY-2

  • tawny-fly
  • 8 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

ALLY-2

ALLY-2

  • aaron
  • 8 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

  • trish-goza
  • 9 Slides

in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...

Sofosbuvir-Velpatasvir in Genotype 2

Sofosbuvir-Velpatasvir in Genotype 2

  • stefany-barnette
  • 0 Slides

ASTRAL-2*. Phase 3. . Treatment. . Naïve &...

Telaprevir

Telaprevir

  • karlyn-bohler
  • 9 Slides

BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...

Hepatitis C Vaccines Michael Houghton

Hepatitis C Vaccines Michael Houghton

  • alida-meadow
  • 0 Slides

University of Alberta. Incidence of HCV Infection...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

  • ellena-manuel
  • 0 Slides

DSV . placebo. Randomisation*. Partial blind. 1...

Elbasvir Grazoprevir

Elbasvir Grazoprevir

  • pamella-moone
  • 0 Slides

Ribavirin in PI-experienced HCV GT1. C-SALVAGE...

ALLY-3 Design Objective SVR

ALLY-3 Design Objective SVR

  • mitsue-stanley
  • 0 Slides

12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...

H. Nina Kim, MD Assistant Professor of Medicine

H. Nina Kim, MD Assistant Professor of Medicine

  • giovanna-bartolotta
  • 0 Slides

Division of Infectious Diseases. University of Wa...

HIV and viral hepatitis co-infection

HIV and viral hepatitis co-infection

  • cheryl-pisano
  • 0 Slides

Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

  • luanne-stotts
  • 0 Slides

. HCV Training Workshop. Version 19.0. HCSP/HCV ...

High HIV, HBV and HCV

High HIV, HBV and HCV

  • stefany-barnette
  • 0 Slides

Prevalence. . among. . People. . Who. . Injec...

Workshops, 2.15-3.15 North Central ODN, led by Professor William Rosenberg, Royal Free: In-reach tr

Workshops, 2.15-3.15 North Central ODN, led by Professor William Rosenberg, Royal Free: In-reach tr

  • trish-goza
  • 0 Slides

Barts. ODN, led by Professor Graham Foster, . Ba...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

  • lois-ondreau
  • 0 Slides

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

Lessons Learned and Novel

Lessons Learned and Novel

  • tatyana-admore
  • 0 Slides

Investigation Techniques . in . Response to a Lar...

Listening to the service user voice:

Listening to the service user voice:

  • yoshiko-marsland
  • 0 Slides

advantages for service delivery design . Magdale...

National Viral Hepatitis Roundtable

National Viral Hepatitis Roundtable

  • ellena-manuel
  • 0 Slides

HCV Baby Boomer Screening . and . Linkage to Care...

July 2017 Lesson 1: Risk

July 2017 Lesson 1: Risk

  • yoshiko-marsland
  • 0 Slides

Behavior . Harm Reduction. Core Competency 2: . P...

Ad Hoc Disease Transmission Advisory Committee (DTAC) Update

Ad Hoc Disease Transmission Advisory Committee (DTAC) Update

  • alexa-scheidler
  • 0 Slides

1. Spring 2018. Questions about reporting potenti...

Advances in the Treatment of

Advances in the Treatment of

  • danika-pritchard
  • 0 Slides

HCV Genotype 3 and HIV/HCV Coinfection . What's S...

What’s New in Hepatitis C

What’s New in Hepatitis C

  • debby-jeon
  • 0 Slides

Diana L. . Sylvestre. , MD. University of CA, San...

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

  • alida-meadow
  • 0 Slides

SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...

PEG alfa-2a RBV versus

PEG alfa-2a RBV versus

  • alexa-scheidler
  • 0 Slides

. PEG alfa-. 2a . versus. INF RBV . APRICOT S...

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

  • min-jolicoeur
  • 0 Slides

Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...

Revised CSTE Case Definition for Acute and Chronic Hepatitis C, 2016

Revised CSTE Case Definition for Acute and Chronic Hepatitis C, 2016

  • calandra-battersby
  • 0 Slides

CalREDIE Local Users Call. December 2, 2015. Rach...

Global Hepatitis C Guidelines 2014: recommendations for a public health approach

Global Hepatitis C Guidelines 2014: recommendations for a public health approach

  • olivia-moreira
  • 0 Slides

Gottfried . Hirnschall. Background . HCV infectio...

AIDS CARE GROUP Grace Paik, CRNP

AIDS CARE GROUP Grace Paik, CRNP

  • marina-yarberry
  • 0 Slides

Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...

Copyright © 2024 DocSlides. All Rights Reserved